March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Reduction in the Incidence of Blindness of all Major Causes in Israel
Author Affiliations & Notes
  • Alon Skaat
    Goldschleger Eye Institute, Sheba Medical Center, Ramat Gan, Israel
  • Michael Kinori
    Goldschleger Eye Institute, Sheba Medical Center, Ramat Gan, Israel
  • Angela Chetrit
    Gertner Institute for Epidemiology & Health Policy Research, Tel Hashomer, Israel
  • Ofra Kalter-Leibovici
    Sackler Faculty of Medicine, Tel Aviv University, Department of Epidemiology and Preventive Medicine, Tel Aviv, Israel
  • Michael Belkin
    Goldschleger Eye Research Institute, Tel-Aviv University, Tel-Hashomer, Israel
  • Footnotes
    Commercial Relationships  Alon Skaat, None; Michael Kinori, None; Angela Chetrit, None; Ofra Kalter-Leibovici, None; Michael Belkin, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3176. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alon Skaat, Michael Kinori, Angela Chetrit, Ofra Kalter-Leibovici, Michael Belkin; Reduction in the Incidence of Blindness of all Major Causes in Israel. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3176.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008.


Descriptive retrospective population-based study. Data was retrieved from the 1999 to 2008 annual reports of the National Registry of the Blind in Israel and retrospectively reviewed. During that decade, 19,862 inhabitants of Israel were newly registered as legally blind. Specific rates by age, gender,calendar year and cause of blindness were calculated. Total and cause-specific annual age-standardized rates were calculated as well. Findings were evaluated by the use of Poisson regression models.


The age-standardized rate of incidence of newly registered legal blindness at the end of the studied decade was half of that at the beginning, declining from 33.8/100,000 in 1999 to 16.6/100,000 in 2008. The decline was due to a decreased incidence of blindness from age-related macular degeneration, glaucoma, diabetic retinopathy and cataract. There was no reduction in the incidence of blindness due to retinitis pigmentosa.


Contemporary interventions in ophthalmology combined with widely available universal free access to healthcare seem to be effective in causing a major reduction in the incidence of blindness.  


Keywords: clinical (human) or epidemiologic studies: prevalence/incidence • age-related macular degeneration • diabetic retinopathy 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.